BPA Call 36C25218A0045-36C25222N0407

<p>The National Human Genome Research Institute issued a BPA call to Roberts Oxygen Co Inc. for liquid nitrogen (VL 160 liters, 22 PSIG with digital gauge) with a ceiling value of $13,588.56, awarded on August 2, 2021. Performance is located in Montgomery Village, Maryland, with an ultimate completion date of July 1, 2022. The call was issued on firm fixed price terms with no set-aside. No parent BPA name is identified in the source documentation.</p>

<p>The National Cancer Institute issued a BPA call to Roberts Oxygen Co Inc. on March 1, 2020, for twice-weekly delivery of liquid nitrogen and cylinder management at the NIH Experimental Immunology Branch in Bethesda, Maryland. The call ceiling is $9,070.11 and carries a firm fixed price. Performance was scheduled to conclude on February 28, 2021. The call was issued to de-obligate expiring FY20 funding lines per NIH OALM communication dated November 5, 2024.</p>

This is a firm fixed-price delivery order awarded by the Defense Health Agency (DHA), a component of the U.S. Department of Defense, to INO Therapeutics LLC, a company that provides inhaled nitric oxide therapy systems and related medical gases. The contract is for the delivery of NITRIC OXIDE MEDICAL GAS with an ultimate completion date of September 30, 2024 and a ceiling value of $29,571.60. The contract was awarded without a set-aside designation and is under the Pharmaceuticals and Drugs GSA...

The Defense Health Agency awarded a $40.2K firm fixed-price purchase order to INO Therapeutics LLC for nitric oxide gas, with a performance location in Bethesda, Maryland and an ultimate completion date of January 31, 2027. This contract represents a child order under INO Therapeutics' larger Blanket Purchase Agreement with the Defense Health Agency, which was established on March 20, 2025, with a $404.2K ceiling value through March 19, 2030. No small business set-aside was applied to this...

This federal contract award is for THERAPEUTIC NITRIC OXIDE SUPPLIES to the National Institutes of Health (NIH) Clinical Center, a civilian agency. The contract was awarded to INO Therapeutics LLC, a foreign-owned, for-profit organization, on September 21, 2017 with a ceiling value of $286,719.70. The contract is a Delivery Order under the Pharmaceuticals and Drugs General Services Administration (GSA) Schedule (FSS-61-IB) and has a Firm Fixed Price pricing type. The contract supports the...

This is a firm fixed-price delivery order awarded by the U.S. Medical Command (MEDCOM) to INO Therapeutics LLC, a prime contractor that provides inhaled nitric oxide therapy systems and related medical gases to U.S. government agencies. The $148,092.00 contract is for the delivery of nitric oxide 800PPM gas to support healthcare programs at the San Antonio Military Medical Center (SAMMC). The award was made under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) without any...

This is a federal contract award from the Department of Veterans Affairs (VA) to INO Therapeutics LLC, a foreign-owned, for-profit organization specializing in providing inhaled nitric oxide therapy systems and related medical gases to federal government healthcare agencies. The contract, with a ceiling value of $2,415.00, is for the delivery of NITRIC OXIDE THERAPY services. The contract is a Delivery Order under the Pharmaceuticals and Drugs GSA Supply Schedule (FSS-61-IB) and has a period...

This is a Firm Fixed Price contract awarded by the Defense Health Agency (DHA) to INO Therapeutics LLC, a foreign-owned for-profit organization, for the provision of inhaled nitric oxide therapeutic gas. The contract, valued at $43,653.60, is a Blanket Purchase Agreement (BPA) Call that will run through September 30, 2025. INO Therapeutics LLC is the prime contractor and there are no mentioned subcontractors. This contract is not set aside and is part of the Pharmaceuticals and Drugs GSA...

This federal contract award was issued by the Department of Veterans Affairs (VA) to INO Therapeutics LLC, a foreign-owned, for-profit organization specializing in providing inhaled nitric oxide therapy systems and related medical gases. The contract, valued at $2,736,038.86, is a Delivery Order under the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB) for NITRIC OXIDE 800PPM GAS. This contract does not have a set-aside designation. INO Therapeutics LLC holds two significant Blanket...

The National Cancer Institute issued a BPA call to Global Life Sciences Solutions USA LLC under the NIH Office of Logistics and Acquisition Operations Blanket Purchase Agreement, with a ceiling value of $14,759.48 and an award date of December 21, 2019. The parent BPA, a $10 million single-award vehicle effective November 29, 2023, through November 30, 2026, enables NIH institutes to procure biological materials, media, chemicals, laboratory supplies, and scientific equipment without...